MedPath

Does Skyla Insertion Timing Impact Bleeding?

Completed
Conditions
Vaginal Bleeding
Interventions
Device: Intrauterine system
Registration Number
NCT03074903
Lead Sponsor
Rutgers, The State University of New Jersey
Brief Summary

Women presenting for contraception will be offered the IUS Skyla and study participation. Daily bleeding will be collected for a total of 90 days and correlated with insertion timing and baseline endometrial thickness.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
132
Inclusion Criteria
  • Women aged 18-45
  • Parous or nulliparous
  • Desire Skyla for contraception
  • Regular menstrual cycles (21-35 days)
  • Working mobile phone and willing to accept text messages and report daily bleeding data for 90 days
Exclusion Criteria
  • Vaginal or cesarean delivery in the past 12 weeks
  • Abortion in the past 6 weeks
  • Uterine anomaly distorting the uterus
  • Acute pelvic inflammatory disease
  • Uterine bleeding of unknown etiology
  • Acute liver disease or tumor
  • History of progestin-sensitive cancer
  • Abnormal pap smear awaiting diagnostic or therapeutic intervention

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Early cycle insertionIntrauterine systemParticipants in this group have the intrauterine system inserted during the first seven days of their menstrual cycle.
Late cycle insertionIntrauterine systemParticipants in this group have the intrauterine system inserted during the remainder of their cycle.
Primary Outcome Measures
NameTimeMethod
Bleeding and spotting as collected by daily texts90 days

Composite variable of bleeding and spotting for 90 days after Skyla IUS insertion

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Planned Parenthood

🇺🇸

Morristown, New Jersey, United States

NJFPC

🇺🇸

Newark, New Jersey, United States

SHS

🇺🇸

Newark, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath